Directive 2001/20/EC
   HOME

TheInfoList



OR:

The Clinical Trials Directive (Officially Directive 2001/20/EC of 4 April 2001, of the
European Parliament The European Parliament (EP) is one of the Legislature, legislative bodies of the European Union and one of its seven Institutions of the European Union, institutions. Together with the Council of the European Union (known as the Council and in ...
and of the Council on the approximation of the laws, regulations and administrative provisions of the Member States relating to implementation of
good clinical practice Good clinical practice (GCP) is an international quality standard, which governments can then transpose into regulations for clinical trials involving human subjects. GCP follows the International Council for Harmonisation of Technical Requirements ...
in the conduct of clinical trials on medicinal products for human use) is a
European Union directive A directive is a legal act of the European Union that requires member states to achieve a particular result without dictating the means of achieving that result. Directives first have to be enacted into national law by member states before thei ...
that aimed at facilitating the internal market in medicinal products within the
European Union The European Union (EU) is a supranational union, supranational political union, political and economic union of Member state of the European Union, member states that are located primarily in Europe, Europe. The union has a total area of ...
, while at the same time maintaining an appropriate level of protection for public health. It seeks to simplify and harmonise the administrative provisions governing
clinical trial Clinical trials are prospective biomedical or behavioral research studies on human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, diet ...
s in the European Community, by establishing a clear, transparent procedure. The Member States of the
European Union The European Union (EU) is a supranational union, supranational political union, political and economic union of Member state of the European Union, member states that are located primarily in Europe, Europe. The union has a total area of ...
had to adopt and publish before 1 May 2003 the laws, regulations and administrative provisions necessary to comply with this Directive. The Member States had to apply these provisions at the latest with effect from 1 May 2004.


The Articles of the Directive

The Articles of the Directive: * Scope (Directive does not apply to non-interventional trials). * Definitions * Protection of clinical trial subjects * Clinical trials on minors * Clinical trials on incapacitated adults not able to give informed legal consent *
Ethics Committee An ethics committee is a body responsible for ensuring that medical experimentation and human subject research are carried out in an ethical manner in accordance with national and international law. Specific regions An ethics committee in the E ...
* Single opinion * Detailed guidance * Commencement of a clinical trial * Conduct of a clinical trial * Exchange of information * Suspension of the trial or infringements * Manufacture and import of investigational medicinal products * Labelling * Verification of compliance of investigational medicinal products with good clinical and manufacturing practice * Notification of
adverse event An adverse event (AE) is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event can ther ...
s * Notification of serious adverse reactions * Guidance concerning reports * General provisions * Adaptation to scientific and technical progress * Committee procedure * Application * Entry into force * Addressees


The effects of the directive

It is considered to have increased the costs of doing clinical trials in the EU, and to have caused the reduction in the number of such trials,The New EU Clinical Trials Regulation: The Good, the Bad, the Ugly
/ref> especially of academic-led studies, and ones looking at new uses for old drugs.print and online Germany derogated from the directive. It is due to be replaced by the EU Clinical Trials Regulation in 2016. The changes are due to come into effect in the second half of 2019.http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000629.jsp&mid=WC0b01ac05808768df


See also

* EudraLex, the collection of rules and regulations governing medicinal products in the European Union * Directive 65/65/EEC1, requires prior approval for marketing of proprietary medicinal products *
Directive 75/318/EEC Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products. This directive of ...
, clarifies requirements of 65/65/EEC1 and requires member states to enforce them *
Directive 75/319/EEC Directive 75/319/EEC of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products. This directive of ...
, requires marketing authorisation requests to be drawn up only by qualified experts *
Directive 93/41/EEC Council of the European Communities Directive 93/41/EEC of 14 June 1993 repealed Directive 87/22/EEC on the approximation of national measures relating to the marketing of high-technology medicinal products, as this directive had been superseded by ...
, establishes the European Agency for the Evaluation of Medicinal Products * Directive 2001/20/EC, defines rules for the conduct of
clinical trials Clinical trials are prospective biomedical or behavioral research studies on human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dieta ...
*
Directive 2001/83/EC Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relates to medicinal products for human use in mainly countries that are part of the European Union. The Directive dealt with the disparitie ...
*
Directive 2005/28/EC {{Use dmy dates, date=July 2018 The Good Clinical Practice Directive (Directive 2005/28/EC of 8 April 2005 of the European Parliament and of the Council) lays down principles and detailed guidelines for good clinical practice as regards conducting ...
, defines Good Clinical Practice for design and conduct of clinical trials *
European Medicines Agency The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of medicinal products. Prior to 2004, it was known as the European Agency for the Evaluation of Medicinal Products or Eur ...
* Regulation of therapeutic goods * Investigator's Brochure


References

{{Reflist
EU information on the Clinical Trials Directive
European clinical research Pharmaceuticals policy European Union directives 2001 in law 2001 in the European Union